Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 8, 2008 - Issue 2
Submit an article Journal homepage
151
Views
22
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Cetuximab plus FOLFOX-4 for fully resected stage III colon carcinoma: scientific background and the ongoing PETACC-8 trial

Julien Taieb Georges Pompidou European Hospital, Hepatogastroenterology Department, 20 rue Leblanc, 75015 Paris, France. [email protected]; [email protected]
,
Pierre Laurent Puig Georges Pompidou European Hospital, Biology Department, 20 rue Leblanc, 75015 Paris, France. [email protected]
&
Laurent Bedenne CHU Dijon & Francophone Federation of Digestive Cancer, Hepatogastroenterology Department, BP 87900 21079, Dijon cedex, France. [email protected]
Pages 183-189 | Published online: 10 Jan 2014

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Basak Oyan. (2012) Why do targeted agents not work in the adjuvant setting in colon cancer?. Expert Review of Anticancer Therapy 12:10, pages 1337-1345.
Read now

Articles from other publishers (21)

Mark Lawler, Brian Johnston, Sandra Van Schaeybroeck, Manuel Salto-Tellez, Richard Wilson, Malcolm Dunlop & Patrick G. Johnston. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 1219 1280.e15 .
Julien Taieb. (2015) La Qualité de vie pendant et après les traitements. Bulletin de l'Académie Nationale de Médecine 199:2-3, pages 223-229.
Crossref
Antonio Russo, Antonio Galvano, Giuseppe Bronte & Marc Peeters. 2015. Targeted Therapies for Solid Tumors. Targeted Therapies for Solid Tumors 147 162 .
Lindsay A. Renfro, Axel Grothey, Yuan Xue, Leonard B. Saltz, Thierry André, Chris Twelves, Roberto Labianca, Carmen J. Allegra, Steven R. Alberts, Charles L. Loprinzi, Greg Yothers & Daniel J. Sargent. (2014) ACCENT-Based Web Calculators to Predict Recurrence and Overall Survival in Stage III Colon Cancer. JNCI: Journal of the National Cancer Institute 106:12.
Crossref
Takeshi Kato. (2014) Perioperative Chemotherapy for Liver Metastases from Colorectal Cancer. Nippon Daicho Komonbyo Gakkai Zasshi 67:10, pages 877-887.
Crossref
Sandra Van Schaeybroeck, Mark Lawler, Brian Johnston, Manuel Salto-Tellez, Jack Lee, Paula Loughlin, Richard Wilson & Patrick G. Johnston. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 1278 1335.e14 .
John R. Goffin & Kevin Zbuk. (2013) Epidermal Growth Factor Receptor: Pathway, Therapies, and Pipeline. Clinical Therapeutics 35:9, pages 1282-1303.
Crossref
Nadine J. McClearyJeffrey A. MeyerhardtErin GreenGreg YothersAimery de GramontEric Van CutsemMichael O'ConnellChristopher J. TwelvesLeonard B. SaltzDaniel G. HallerDaniel J. Sargent. (2013) Impact of Age on the Efficacy of Newer Adjuvant Therapies in Patients With Stage II/III Colon Cancer: Findings From the ACCENT Database. Journal of Clinical Oncology 31:20, pages 2600-2606.
Crossref
Efat Azizi, Adam Kittai & Peter Kozuch. (2012) Antiepidermal Growth Factor Receptor Monoclonal Antibodies: Applications in Colorectal Cancer. Chemotherapy Research and Practice 2012, pages 1-15.
Crossref
Samer-ul Haque, Dion Morton & Hazel Welch. (2012) Biologics against cancer-specific receptors – challenges to personalised medicine from early trial results. Current Opinion in Pharmacology 12:4, pages 392-397.
Crossref
Gustavo Werutsky, Michel Ducreux, Manfred Lutz, Murielle Mauer, Eric Van Cutsem, Theo Ruers, Gunnar Folprecht, Markus Moehler, Daniela Aust, Jean-Luc Van Laethem, Florian Lordick, Bernard Nordlinger & Arnaud Roth. (2012) The EORTC Gastrointestinal Tract Cancer Group: 50 years of research contributing to improved gastrointestinal cancer management. European Journal of Cancer Supplements 10:1, pages 51-57.
Crossref
S. Tejpar, Z. Saridaki, M. Delorenzi, F. Bosman & A. D. Roth. (2011) Microsatellite Instability, Prognosis and Drug Sensitivity of Stage II and III Colorectal Cancer: More Complexity to the Puzzle. JNCI Journal of the National Cancer Institute 103:11, pages 841-844.
Crossref
Jean-François Morère, Françoise Mornex & Denis SoulièresJ.-B. Bachet, J. Taïeb, E. Mitry & P. Rougier. 2011. Thérapeutique du cancer. Thérapeutique du cancer 359 386 .
Fang NIE, Jun SHEN, Jin Lu TONG, Xi Tao XU, Ming Ming ZHU & Zhi Hua RAN. (2009) Meta-analysis: The efficacy and safety of monoclonal antibody targeted to epidermal growth factor receptor in the treatment of patients with metastatic colorectal cancer. Journal of Digestive Diseases 10:4, pages 247-257.
Crossref
Julien Taieb, Pierre Laurent-Puig & Steven Alberts. (2009) Incidence of KRAS status in ongoing adjuvant trials in colon cancer. Current Colorectal Cancer Reports 5:3, pages 171-178.
Crossref
Corrado Boni, Thierry André, Maria Chiara Banzi, Tamas Hickish, Josep Tabernero, Philip Clingan, Benoist Chibaudel & Aimery de Gramont. (2009) Similarities and differences between the adjuvant oxaliplatin-based trials MOSAIC and NSABP C-07. Current Colorectal Cancer Reports 5:3, pages 166-170.
Crossref
Arduino Verdecchia, Stefano Guzzinati, Silvia Francisci, Roberta De Angelis, Freddie Bray, Claudia Allemani, Andrea Tavilla, Mariano Santaquilani & Milena Sant. (2009) Survival trends in European cancer patients diagnosed from 1988 to 1999. European Journal of Cancer 45:6, pages 1042-1066.
Crossref
J. Taieb. 2009. Post’U FMC-HGE. Post’U FMC-HGE 47 55 .
Andrea Bonetti & Furini Lara. 2009. Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy. Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy 271 284 .
Kim M Smits, Arjen HG ClevenMatty P Weijenberg, Laura AE Hughes, James G Herman, Adriaan P de BruïneManon van Engeland. (2008) Pharmacoepigenomics in colorectal cancer: a step forward in predicting prognosis and treatment response. Pharmacogenomics 9:12, pages 1903-1916.
Crossref
Heinz-Josef Lenz. (2008) First-line combination treatment of colorectal cancer with hepatic metastases: Choosing a targeted agent. Cancer Treatment Reviews 34, pages S3-S7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.